Federated Hermes
CMPX icon

Federated Hermes’s Compass Therapeutics CMPX Stock Holding History

Federated Hermes’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5K Buy
+7,522
New +$22.2K ﹤0.01% 1800
2024
Q3 		– Sell
-3,592
Closed -$3.59K – 2076
2024
Q2 		$3.59K Buy
3,592
+2,659
+285% +$3.88K ﹤0.01% 1869
2024
Q1 		$1.85K Sell
933
-2,608
-74% -$4.51K ﹤0.01% 1927
2023
Q4 		$5.52K Buy
+3,541
New +$6.13K ﹤0.01% 1841

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Federated Hermes's CMPX Position: Q2 2026 in Review

Federated Hermes opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 7,522 shares worth $16.5K. The stake represents ﹤0.01% of the portfolio and ranks #1800 among its holdings. This is a return to the name: Federated Hermes previously reported a position in CMPX as recently as Q2 2024.

Federated Hermes first reported a position in CMPX in Q4 2023 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Federated Hermes held 7,522 shares of Compass Therapeutics worth $16.5K as of Q2 2026.
  • Compass Therapeutics was a new Federated Hermes position in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1800 holding.
  • Federated Hermes first reported a position in Compass Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.